| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 114 | 283 | 2.161 | 2.446 | 5.070 |
| Total Income - EUR | - | - | 0 | 0 | 0 | 114 | 283 | 2.166 | 2.446 | 5.070 |
| Total Expenses - EUR | - | - | 337 | 47 | 70 | 383 | 598 | 1.331 | 2.143 | 3.732 |
| Gross Profit/Loss - EUR | - | - | -337 | -47 | -70 | -269 | -315 | 835 | 303 | 1.338 |
| Net Profit/Loss - EUR | - | - | -337 | -47 | -70 | -272 | -324 | 770 | 255 | 1.147 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medicina Pentru Suflet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 79 | 85 | 13 | 65 | 89 | 398 | 1.540 | 4.759 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 10 | 0 | 0 | 10 | 136 |
| Cash | - | - | 79 | 85 | 13 | 54 | 89 | 398 | 1.530 | 4.623 |
| Shareholders Funds | - | - | -293 | -334 | -397 | -662 | -971 | -204 | 52 | 1.198 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 372 | 419 | 411 | 727 | 1.060 | 602 | 1.488 | 3.561 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9609 - 9609" | |||||||||
| CAEN Financial Year |
9609
|
|||||||||
Comments - Medicina Pentru Suflet Srl